LU61171A1 - - Google Patents

Info

Publication number
LU61171A1
LU61171A1 LU61171A LU61171A LU61171A1 LU 61171 A1 LU61171 A1 LU 61171A1 LU 61171 A LU61171 A LU 61171A LU 61171 A LU61171 A LU 61171A LU 61171 A1 LU61171 A1 LU 61171A1
Authority
LU
Luxembourg
Application number
LU61171A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU61171A1 publication Critical patent/LU61171A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU61171A 1969-06-24 1970-06-22 LU61171A1 (https=)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19691931910 DE1931910B2 (de) 1969-06-24 1969-06-24 Verfahren zur Herstellung fester, steuerbar resorbierbarer Arzneimittelzubereitungen schwer löslicher Wirkstoffe

Publications (1)

Publication Number Publication Date
LU61171A1 true LU61171A1 (https=) 1970-08-26

Family

ID=5737829

Family Applications (1)

Application Number Title Priority Date Filing Date
LU61171A LU61171A1 (https=) 1969-06-24 1970-06-22

Country Status (10)

Country Link
JP (1) JPS50888B1 (https=)
AT (1) AT299452B (https=)
DE (1) DE1931910B2 (https=)
DK (1) DK125230B (https=)
FI (1) FI51765C (https=)
FR (1) FR2053007A1 (https=)
LU (1) LU61171A1 (https=)
NL (1) NL167322C (https=)
NO (1) NO131864C (https=)
SE (1) SE380729B (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2407720A1 (fr) * 1977-11-08 1979-06-01 Lipha Lyonnaise Indle Pharmace Preparations pharmaceutiques orales a activite therapeutique prolongee
EP0568026A3 (en) * 1992-04-28 1993-11-10 Ss Pharmaceutical Co., Ltd. Piroxicam tablets and production process thereof

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2403080A1 (fr) * 1977-09-15 1979-04-13 Heyden Chem Fab Preparation de nitrofurantoine a effet retard pour administration orale et son procede de fabrication
US4370313A (en) * 1981-10-26 1983-01-25 Eaton Laboratories, Inc. Nitrofurantoin dosage form
JPS61135913U (https=) * 1985-02-12 1986-08-23
AR016827A1 (es) 1997-08-22 2001-08-01 Smithkline Beecham Corp PROCEDIMIENTO PARA LA PREPARACIoN DE UNA TABLETA FARMACÉUTICA
AR017512A1 (es) 1997-08-22 2001-09-12 Smithkline Beecham Corp Tabletas de metilcelulosa rapidamente desintegrables para administracion por via oral y procedimiento para prepararlas

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE536822A (https=) * 1954-03-25
BE556141A (https=) * 1956-03-27

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2407720A1 (fr) * 1977-11-08 1979-06-01 Lipha Lyonnaise Indle Pharmace Preparations pharmaceutiques orales a activite therapeutique prolongee
EP0568026A3 (en) * 1992-04-28 1993-11-10 Ss Pharmaceutical Co., Ltd. Piroxicam tablets and production process thereof
US5654002A (en) * 1992-04-28 1997-08-05 Ss Pharmaceutical Co., Ltd. Piroxicam tablets and production and process thereof

Also Published As

Publication number Publication date
NL167322C (nl) 1981-12-16
AT299452B (de) 1972-06-26
DE1931910A1 (de) 1971-01-07
FI51765B (https=) 1976-12-31
FR2053007B1 (https=) 1974-08-30
NO131864B (https=) 1975-05-12
NO131864C (https=) 1975-08-20
JPS50888B1 (https=) 1975-01-13
FI51765C (fi) 1977-04-12
SE380729B (sv) 1975-11-17
DK125230B (da) 1973-01-22
DE1931910B2 (de) 1974-11-28
FR2053007A1 (en) 1971-04-16
NL7009172A (https=) 1970-12-29

Similar Documents

Publication Publication Date Title
CS152345B2 (https=)
AU429630B2 (https=)
AU5461069A (https=)
FI51765B (https=)
AU2355770A (https=)
AU427401B2 (https=)
CS149943B2 (https=)
AU414607B2 (https=)
AU417208B2 (https=)
AU428074B2 (https=)
AU438128B2 (https=)
AU425297B2 (https=)
AU442285B2 (https=)
AU410358B2 (https=)
AU5228269A (https=)
CS153654B1 (https=)
AU5079269A (https=)
AU5109569A (https=)
AU4923469A (https=)
CS149928B2 (https=)
AU5598769A (https=)
BE748772A (https=)
AU3858369A (https=)
BE733530A (https=)
AU5006968A (https=)